Return on Capital Employed Insights for Personalis
Pulled from Benzinga Pro data Personalis (NASDAQ:PSNL) reported Q2 sales of $21.67 million. Earnings fell to a loss of $14.95 million, resulting in a 19.67% decrease from last quarter.
Stocks That Hit 52-Week Lows On Friday
On Friday morning, 155 companies achieved new lows for the year.
Stocks That Hit 52-Week Lows On Thursday
Thursday morning, 173 companies reached new 52-week lows.
Recap: Personalis Q2 Earnings
Shares of Personalis (NASDAQ:PSNL) fell 1.8% in after-market trading after the company reported Q2 results.
Quarterly Results
Earnings per share were down 17.24% year over year to ($0.34), which beat the estimate of ($0.39).
Personalis Q2 EPS $(0.34) Beats $(0.39) Estimate, Sales $21.70M Beat $21.21M Estimate
Personalis (NASDAQ:PSNL) reported quarterly losses of $(0.34) per share which beat the analyst consensus estimate of $(0.39) by 12.82 percent. This is a 17.24 percent decrease over losses of $(0.29) per share from the
Earnings Scheduled For August 4, 2021
Companies Reporting Before The Bell
• UroGen Pharma (NASDAQ:URGN) is projected to report earnings for its second quarter.
Personalis Highlights Publication Of Its Study ‘Prediction of immunotherapy response in melanoma through combined modeling of neoantigen burden and immune-related resistance mechanisms’ In Clinical Cancer Research Journal
Personalis, Inc. (NASDAQ:PSNL), a leader in advanced translational genomics and diagnostics for cancer, today announced the publication of its study "Prediction of immunotherapy response in melanoma through combined
Earnings Scheduled For May 5, 2021
Companies Reporting Before The Bell
• Monmouth Real Estate (NYSE:MNR) is likely to report earnings for its second quarter.